
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
Export 49 results:
Author Title Type [ Year
Filters: Author is Dell'Aniello, S. [Clear All Filters]
“Hormone replacement therapy use and the risk of stroke”, Maturitas, vol. 61, pp. 305-9, 2008.
, “Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study”, Pharmacoepidemiol Drug Saf, vol. 19, pp. 335-42, 2010.
, “Hormone replacement therapy and the risk of venous thromboembolism: a population-based study”, J Thromb Haemost, vol. 8, pp. 979-86, 2010.
, “Thiazolidinediones and the risk of incident strokes in patients with type 2 diabetes: a nested case-control study”, Pharmacoepidemiol Drug Saf, vol. 19, pp. 343-50, 2010.
, “Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study”, Bmj, vol. 340, p. c2519, 2010.
, , “Concurrent use of tamoxifen with CYP2D6 inhibitors and the risk of breast cancer recurrence”, Breast Cancer Res Treat, vol. 126, pp. 695-703, 2011.
, “Long-term effects of insulin glargine on the risk of breast cancer”, Diabetologia, vol. 54, pp. 2254-62, 2011.
, “Metformin and the incidence of prostate cancer in patients with type 2 diabetes”, Cancer Epidemiol Biomarkers Prev, vol. 20, pp. 337-44, 2011.
, “Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study”, BMC Pulm Med, vol. 11, p. 59, 2011.
, “Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer”, Br J Cancer, vol. 104, pp. 1558-63, 2011.
, “Dopamine agonist use and the risk of heart failure”, Pharmacoepidemiol Drug Saf, vol. 21, pp. 34-41, 2012.
, “Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case-control study”, Breast Cancer Res Treat, vol. 135, pp. 603-9, 2012.
, “A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case-control study”, BMC Cardiovasc Disord, vol. 12, p. 49, 2012.
, “Pramipexole use and the risk of pneumonia”, BMC Neurol, vol. 12, p. 113, 2012.
, “The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation”, Thromb Haemost, vol. 109, pp. 431-9, 2013.
, “Cardiac glycosides and the risk of breast cancer in women with chronic heart failure and supraventricular arrhythmia”, Breast Cancer Res Treat, vol. 146, pp. 619-26, 2014.
, “Cardiac glycosides use and the risk of lung cancer: a nested case-control study”, BMC Cancer, vol. 14, p. 573, 2014.
, “Concurrent use of statins and hormone therapy and risk of venous thromboembolism in postmenopausal women: a population-based case-control study”, Menopause, vol. 21, pp. 1023-6, 2014.
, “Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes”, Eur Heart J, vol. 35, pp. 1881-7, 2014.
, “Measuring persistence to hormonal therapy in patients with breast cancer: accounting for temporary treatment discontinuation”, Pharmacoepidemiol Drug Saf, vol. 23, pp. 882-9, 2014.
, “The use of antidepressants and the risk of idiopathic pulmonary arterial hypertension”, Can J Cardiol, vol. 30, pp. 1633-9, 2014.
, “Antiepileptic drugs and the risk of ischaemic stroke and myocardial infarction: a population-based cohort study”, BMJ Open, vol. 5, p. e008365, 2015.
, “Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995-2015”, Br J Clin Pharmacol, vol. 82, pp. 858-68, 2016.
, “Statins and Risk of Rheumatoid Arthritis: A Nested Case-Control Study”, Arthritis Rheumatol, vol. 68, pp. 2603-2611, 2016.
, “The Use of Telmisartan and the Incidence of Cancer”, Am J Hypertens, vol. 29, pp. 1358-1365, 2016.
, “Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease”, Br J Clin Pharmacol, vol. 82, pp. 461-72, 2016.
, “Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage”, JAMA Neurol, vol. 74, pp. 173-180, 2017.
, “Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 554-560, 2017.
, “Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events”, Eur Respir J, vol. 49, 2017.
, “The effect of statins on influenza-like illness morbidity and mortality”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 63-70, 2017.
, “Long-Acting Bronchodilator Initiation in COPD and the Risk of Adverse Cardiopulmonary Events: A Population-Based Comparative Safety Study”, Chest, vol. 151, pp. 60-67, 2017.
, “Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 459-468, 2017.
, “Trends in the prescription of novel oral anticoagulants in UK primary care”, Br J Clin Pharmacol, vol. 83, pp. 2096-2106, 2017.
, “Comparative effect of statins on the risk of incident Alzheimer disease”, Neurology, vol. 90, pp. e179-e187, 2018.
, “Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study”, Lancet Respir Med, vol. 6, pp. 855-862, 2018.
, , , “Association of Aripiprazole With the Risk for Psychiatric Hospitalization, Self-harm, or Suicide”, JAMA Psychiatry, 2019.
, “Cardiovascular and cerebrovascular safety of testosterone replacement therapy among aging men with low testosterone levels: a cohort study.”, Am J Med, 2019.
, “Comparative cardiovascular and hypoglycemic safety of glimepiride in type 2 diabetes: A population-based cohort study”, Diabetes Obes Metab, 2019.
, “Comparative effectiveness and safety of LABA-LAMA versus LABA-ICS treatment of COPD in real world clinical practice”, Chest, 2019.
, , “Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study”, Neurology, vol. 93, pp. e1010-e1020, 2019.
, “Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research”, Pharmacoepidemiol Drug Saf, 2019.
, “Beta 2 agonists and the incidence of Parkinson's disease”, Am J Epidemiol, 2020.
, “Comparative Effectiveness of Initial LAMA versus LABA in COPD: Real-World Cohort Study”, Copd, vol. 18, pp. 1-8, 2021.
, “Infectious Disease Burden and the Risk of Alzheimer's Disease: A Population-Based Study”, J Alzheimers Dis, 2021.
, “Prescribing Trends of Antidepressants and Psychotropic Coprescription for Youths in UK Primary Care, 2000-2018”, J Affect Disord, vol. 287, pp. 19-25, 2021.
,